Elizabeth Maleche-Obimbo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elizabeth Maleche-Obimbo has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Grace John-Stewart
Department of Global Health, University of Washington, Seattle, USA
5 shared publications - Barbra A. Richardson
Department of Global Health, University of Washington, Seattle, Washington, United States of America
3 shared publications Fredrick Were
Affiliation Department of Paediatrics & Child Health, Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya
3 shared publications- Jaclyn N. Escudero
Department of Global Health, University of Washington , Seattle, Washington
3 shared publications - Jerphason Mecha
Centre for Respiratory Diseases Research, Kenya Medical Research Institute , Nairobi
3 shared publications - Sylvia M. LaCourse
Department of Global Health, University of Washington , Seattle, Washington
3 shared publications
Latest Publications
- Open Access
- 21 January 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (4) , e981-e989
Mycobacterium tuberculosis– Specific CFP-10/ESAT-6 CD4 and CD8 T-Cell Non-IFN-γ+ Responses Are Common in Young Kenyan Children Despite Low Reported Tuberculosis Exposure
Background: Reduced early-life interferon-γ (IFN-γ) production capacity may limit sensitivity of IFN-γ release assays to detect Mycobacterium tuberculosis (Mtb)–specific responses in young children. Measuring non-IFN-γ cytokine responses may improve detection. Methods: Mononuclear cells isolated from peripheral blood from children exposed to HIV but uninfected and children unexposed to HIV in Western Kenya were collected at 6 to 10 weeks, and 12 and 24 months of age. Cells were incubated overnight with Mtb-specific CFP-10/ESAT-6 peptides and Staphylococcus enterotoxin B (positive control). CD4 and CD8 T-cell expression of IFN-γ and IL-2 and TNF cytokines was measured by flow cytometry. Results: Among 213 children, 28.6% had CFP-10/ESAT-6-specific CD4 and/or CD8 responses through 24 months. No children with Mtb-specific responses had a reported tuberculosis exposure. Mtb-specific non-IFN-γ+ responses (IL-2+ and/or TNF+) were more common than IFN-γ+ responses (26.3% vs 10.3%, P < .001). Non-IFN-γ cytokines alone identified 18.3% of children, compared with 2.4% identified by IFN-γ+ responses alone (P < .001). Prevalence of Mtb-specific responses was similar regardless of HIV exposure (HIV exposed, 31.5%; HIV unexposed, 25.5%, P = .33). At 6 to 10 weeks, children were more likely to have non-IFN-γ+ than IFN-γ+ responses to the positive control (96.3% vs 77.8%, P = .004); by 24 months, all children mounted both IFN-γ+ and non-IFN-γ+ responses. Conclusions: Mtb-specific CD4/CD8 responses were common among Kenyan children through 24 months, despite limited reported tuberculosis exposures. Non-IFN-γ+ cytokine expression identified substantially more children than IFN-γ+ alone, suggesting current IFN-γ release assays may miss early-life Mtb-specific responses.
- 21 January 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (4) , e981-e989
Open AccessMycobacterium tuberculosis– Specific CFP-10/ESAT-6 CD4 and CD8 T-Cell Non-IFN-γ+ Responses Are Common in Young Kenyan Children Despite Low Reported Tuberculosis Exposure
Background: Reduced early-life interferon-γ (IFN-γ) production capacity may limit sensitivity of IFN-γ release assays to detect Mycobacterium tuberculosis (Mtb)–specific responses in young children. Measuring non-IFN-γ cytokine responses may improve detection. Methods: Mononuclear cells isolated from peripheral blood from children exposed to HIV but uninfected and children unexposed to HIV in Western Kenya were collected at 6 to 10 weeks, and 12 and 24 months of age. Cells were incubated overnight with Mtb-specific CFP-10/ESAT-6 peptides and Staphylococcus enterotoxin B (positive control). CD4 and CD8 T-cell expression of IFN-γ and IL-2 and TNF cytokines was measured by flow cytometry. Results: Among 213 children, 28.6% had CFP-10/ESAT-6-specific CD4 and/or CD8 responses through 24 months. No children with Mtb-specific responses had a reported tuberculosis exposure. Mtb-specific non-IFN-γ+ responses (IL-2+ and/or TNF+) were more common than IFN-γ+ responses (26.3% vs 10.3%, P < .001). Non-IFN-γ cytokines alone identified 18.3% of children, compared with 2.4% identified by IFN-γ+ responses alone (P < .001). Prevalence of Mtb-specific responses was similar regardless of HIV exposure (HIV exposed, 31.5%; HIV unexposed, 25.5%, P = .33). At 6 to 10 weeks, children were more likely to have non-IFN-γ+ than IFN-γ+ responses to the positive control (96.3% vs 77.8%, P = .004); by 24 months, all children mounted both IFN-γ+ and non-IFN-γ+ responses. Conclusions: Mtb-specific CD4/CD8 responses were common among Kenyan children through 24 months, despite limited reported tuberculosis exposures. Non-IFN-γ+ cytokine expression identified substantially more children than IFN-γ+ alone, suggesting current IFN-γ release assays may miss early-life Mtb-specific responses.
- Open Access
- 7 January 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (2)
C-reactive protein for pulmonary tuberculosis screening and treatment response monitoring in children
C-reactive protein was evaluated as a biomarker for pulmonary tuberculosis diagnosis and treatment response monitoring in 292 Kenyan children. Although diagnostic sensitivity was suboptimal (35.5-50.0%), median CRP decreased during TB treatment in children with confirmed (p=0.02) and unconfirmed TB (p<0.001), primarily among those with baseline CRP elevation ≥5mg/L, 40% (39/97).
- 7 January 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (2)
Open AccessC-reactive protein for pulmonary tuberculosis screening and treatment response monitoring in children
C-reactive protein was evaluated as a biomarker for pulmonary tuberculosis diagnosis and treatment response monitoring in 292 Kenyan children. Although diagnostic sensitivity was suboptimal (35.5-50.0%), median CRP decreased during TB treatment in children with confirmed (p=0.02) and unconfirmed TB (p<0.001), primarily among those with baseline CRP elevation ≥5mg/L, 40% (39/97).
- Open Access
- 18 November 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (11) , e0005453
Educational attainment and self-reported environmental exposures of pregnant women living in Nairobi, Kenya
Environmental exposures experienced by pregnant women living in cities of low- and middle-income countries are poorly described. We collected information on housing characteristics, household and ambient air pollution, and work-related exposures through questionnaires in a cohort of 400 pregnant women in Nairobi, Kenya and examined exposures in relation to educational attainment, a proxy for socioeconomic status. Participants were median 26 years of age, mostly married (85%) and self-described homemakers (54%), with at least some secondary school education (74%). Housing generally consisted of one room (58%) with one window (57%), access to electricity (94%), and no piped water (88%). Participants commonly reported living near sewers (55%) and the Dandora dumpsite (34%). Liquified petroleum gas (LPG) was the primary domestic cooking fuel, followed by kerosene, with 65% and 32%, respectively, reporting use most days to daily. Most participants reported exposure to outdoor cooking smoke (73%) and vehicle exhaust (66%) most days to daily. Employed participants (N = 151) reported work-related exposure to vehicle exhaust (68%), cigarettes (37%), marijuana (33%), dusty/unpaved roads (32%), welding (30%), and the dumpsite (30%) most days to daily. Exposure to rubbish burning was reported by 4.5% of participants at home, by 24% outdoors, and by 25% related to work most days to daily. Relative to women with primary school education or lower, women with at least secondary school education were more likely to use LPG (p < 0.001) and less likely to use kerosene (p < 0.001). This study highlights a high prevalence of pregnant women in an urban African context experience multiple sources of combustion related air pollution sources. Exposure to cooking emissions, vehicle exhaust, and rubbish burning were frequent. Kerosene, the second most common and a dirty domestic fuel, was used more by women with lower educational attainment. These data may inform future studies of prenatal and early childhood environmental exposures and interventions.
- 18 November 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (11) , e0005453
Open AccessEducational attainment and self-reported environmental exposures of pregnant women living in Nairobi, Kenya
Environmental exposures experienced by pregnant women living in cities of low- and middle-income countries are poorly described. We collected information on housing characteristics, household and ambient air pollution, and work-related exposures through questionnaires in a cohort of 400 pregnant women in Nairobi, Kenya and examined exposures in relation to educational attainment, a proxy for socioeconomic status. Participants were median 26 years of age, mostly married (85%) and self-described homemakers (54%), with at least some secondary school education (74%). Housing generally consisted of one room (58%) with one window (57%), access to electricity (94%), and no piped water (88%). Participants commonly reported living near sewers (55%) and the Dandora dumpsite (34%). Liquified petroleum gas (LPG) was the primary domestic cooking fuel, followed by kerosene, with 65% and 32%, respectively, reporting use most days to daily. Most participants reported exposure to outdoor cooking smoke (73%) and vehicle exhaust (66%) most days to daily. Employed participants (N = 151) reported work-related exposure to vehicle exhaust (68%), cigarettes (37%), marijuana (33%), dusty/unpaved roads (32%), welding (30%), and the dumpsite (30%) most days to daily. Exposure to rubbish burning was reported by 4.5% of participants at home, by 24% outdoors, and by 25% related to work most days to daily. Relative to women with primary school education or lower, women with at least secondary school education were more likely to use LPG (p < 0.001) and less likely to use kerosene (p < 0.001). This study highlights a high prevalence of pregnant women in an urban African context experience multiple sources of combustion related air pollution sources. Exposure to cooking emissions, vehicle exhaust, and rubbish burning were frequent. Kerosene, the second most common and a dirty domestic fuel, was used more by women with lower educational attainment. These data may inform future studies of prenatal and early childhood environmental exposures and interventions.
- Open Access
- 9 July 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (7) , e0004818
Effect of diet video-drama and telephone messages on improving parental knowledge and diet diversity of malnourished children in Kenya: A randomised controlled trial
Severe acute malnutrition (SAM) accounts for 1 million deaths globally each year. Ready-to-use Therapeutic Food (RUTF), recommended for treatment, is often replaced with low-nutrient home foods. We sought to determine the effect of enhanced caregiver counselling, using a dramatized video with contextualized demonstrations of local high-nutrient food (video-drama) and telephone messages on high-nutrient foods (SMS), on children’s dietary diversity scores (DDS), weight gain, and caregiver knowledge. This randomised trial enrolled 213 severely malnourished children and caregivers at Mbagathi Hospital in Nairobi. Children were randomised to 3 study arms: standard of care (SOC) (children received RUTF, caregivers received routine nutrition counselling); intervention arm A (caregivers watched the video-drama at enrolment, 1- and 6-weeks post-enrolment plus SOC); and intervention arm B (caregivers received weekly SMS, watched the video-drama plus SOC). Primary outcome was DDS, secondary outcomes were weight gain and caregiver knowledge. Median DDS, mean rate of weight gain and caregiver knowledge were compared between trial arms using Kruskal-Wallis and ANOVA tests, respectively. Children’s median age at enrolment was 12 months (IQR 8.0, 16.0), 50.7% were female, 74.6% were breastfeeding and 78.9% were on RUTF. Median caregiver age was 28 years (IQR 24.5, 32.0) and 98% were female. Post-intervention, children in arms A and B had significantly higher median DDS at 5 (IQR 4, 5) versus 4 (IQR 3, 5) in SOC arm (p < 0.001)]. Mean caregiver knowledge was significantly higher in arm A (4.53[±1.17)] and arm B (4.27[±1.04]) compared to 3.77(±0.91) in SOC (p < 0.001). Mean rate of weight gain was similar across study arms [7.60 g/kg/day in intervention arms, 7.30 g/kg/day for SOC (p-value 0.31)]. Video-drama enhanced SOC counselling of local high-nutrient foods, improved children’s DDS and caregiver knowledge, but did not improve short-term weight gain. Weekly SMS did not provide additional benefits to the video-drama.
- 9 July 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (7) , e0004818
Open AccessEffect of diet video-drama and telephone messages on improving parental knowledge and diet diversity of malnourished children in Kenya: A randomised controlled trial
Severe acute malnutrition (SAM) accounts for 1 million deaths globally each year. Ready-to-use Therapeutic Food (RUTF), recommended for treatment, is often replaced with low-nutrient home foods. We sought to determine the effect of enhanced caregiver counselling, using a dramatized video with contextualized demonstrations of local high-nutrient food (video-drama) and telephone messages on high-nutrient foods (SMS), on children’s dietary diversity scores (DDS), weight gain, and caregiver knowledge. This randomised trial enrolled 213 severely malnourished children and caregivers at Mbagathi Hospital in Nairobi. Children were randomised to 3 study arms: standard of care (SOC) (children received RUTF, caregivers received routine nutrition counselling); intervention arm A (caregivers watched the video-drama at enrolment, 1- and 6-weeks post-enrolment plus SOC); and intervention arm B (caregivers received weekly SMS, watched the video-drama plus SOC). Primary outcome was DDS, secondary outcomes were weight gain and caregiver knowledge. Median DDS, mean rate of weight gain and caregiver knowledge were compared between trial arms using Kruskal-Wallis and ANOVA tests, respectively. Children’s median age at enrolment was 12 months (IQR 8.0, 16.0), 50.7% were female, 74.6% were breastfeeding and 78.9% were on RUTF. Median caregiver age was 28 years (IQR 24.5, 32.0) and 98% were female. Post-intervention, children in arms A and B had significantly higher median DDS at 5 (IQR 4, 5) versus 4 (IQR 3, 5) in SOC arm (p < 0.001)]. Mean caregiver knowledge was significantly higher in arm A (4.53[±1.17)] and arm B (4.27[±1.04]) compared to 3.77(±0.91) in SOC (p < 0.001). Mean rate of weight gain was similar across study arms [7.60 g/kg/day in intervention arms, 7.30 g/kg/day for SOC (p-value 0.31)]. Video-drama enhanced SOC counselling of local high-nutrient foods, improved children’s DDS and caregiver knowledge, but did not improve short-term weight gain. Weekly SMS did not provide additional benefits to the video-drama.
- Open Access
- 31 January 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (2) , ofaf067
Diminished Mycobacterium tuberculosis–specific T-cell Responses During Pregnancy in Women With HIV and Receiving Isoniazid Preventive Therapy
Background: Pregnancy increases Mycobacterium tuberculosis (Mtb) reactivation risk and alters immune responses. We assessed Mtb-specific CD4+ T-cell responses in pregnant women with HIV (WLHIV) and without, including those receiving isoniazid preventive therapy (IPT). Methods: We measured adaptive immune responses from 33 participants (HIV+ 21, HIV− 12) with positive interferon-gamma release assay during pregnancy (20–34 weeks’ gestation), 6 weeks, and 12 months postpartum by intracellular cytokine staining. We measured overall responses using COMPASS and made comparisons by nonparametric analysis of variance. Result: We observed diminished Mtb-specific CD4+ T-cell responses in WLHIV during pregnancy versus 12 months postpartum (COMPASS median functional score [FS] .009 vs 0.12, P = .03). WLHIV who received IPT (n = 8) during concurrent pregnancy had attenuated Mtb-specific CD4+ T-cell responses during pregnancy versus 12 months postpartum (median FS 8.3 × 10−7 vs 0.13, P = .02), but WLHIV who did not receive IPT during pregnancy had similar responses in pregnancy and postpartum. Mtb-specific CD8+ FS was increased postpartum in all groups. We found preexisting Mtb-specific CD4+ T-cell responses in participants who converted interferon-gamma release assay tests postpartum (n = 10). Conclusions: Pregnant WLHIV, especially those on IPT, showed reduced Mtb-specific CD4+ T-cell responses. Understanding the impact of pregnancy on Mtb-specific T-cell responses may improve diagnostic approaches.
- 31 January 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (2) , ofaf067
Open AccessDiminished Mycobacterium tuberculosis–specific T-cell Responses During Pregnancy in Women With HIV and Receiving Isoniazid Preventive Therapy
Background: Pregnancy increases Mycobacterium tuberculosis (Mtb) reactivation risk and alters immune responses. We assessed Mtb-specific CD4+ T-cell responses in pregnant women with HIV (WLHIV) and without, including those receiving isoniazid preventive therapy (IPT). Methods: We measured adaptive immune responses from 33 participants (HIV+ 21, HIV− 12) with positive interferon-gamma release assay during pregnancy (20–34 weeks’ gestation), 6 weeks, and 12 months postpartum by intracellular cytokine staining. We measured overall responses using COMPASS and made comparisons by nonparametric analysis of variance. Result: We observed diminished Mtb-specific CD4+ T-cell responses in WLHIV during pregnancy versus 12 months postpartum (COMPASS median functional score [FS] .009 vs 0.12, P = .03). WLHIV who received IPT (n = 8) during concurrent pregnancy had attenuated Mtb-specific CD4+ T-cell responses during pregnancy versus 12 months postpartum (median FS 8.3 × 10−7 vs 0.13, P = .02), but WLHIV who did not receive IPT during pregnancy had similar responses in pregnancy and postpartum. Mtb-specific CD8+ FS was increased postpartum in all groups. We found preexisting Mtb-specific CD4+ T-cell responses in participants who converted interferon-gamma release assay tests postpartum (n = 10). Conclusions: Pregnant WLHIV, especially those on IPT, showed reduced Mtb-specific CD4+ T-cell responses. Understanding the impact of pregnancy on Mtb-specific T-cell responses may improve diagnostic approaches.
- Open Access
- 21 January 2024
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 115 (5) , 1105-1113
Population Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in Africa
Antiretroviral therapy for children living with HIV (CLHIV) under 3 years of age commonly includes lopinavir/ritonavir (LPV/r). However, the original liquid LPV/r formulation has taste and cold storage difficulties. To address these challenges, LPV/r oral pellets have been developed. These pellets can be mixed with milk or food for administration and do not require refrigeration. We developed the population pharmacokinetic (PK) model and assessed drug exposure of LPV/r oral pellets administered twice daily to CLHIV per World Health Organization (WHO) weight bands. The PK analysis included Kenyan and Ugandan children participating in the LIVING studies (NCT02346487) receiving LPV/r pellets (40/10 mg) and ABC/3TC (60/30 mg) dispersible tablets. Population PK models were developed for lopinavir (LPV) and ritonavir (RTV) to evaluate the impact of RTV on the oral clearance (CL/F) of LPV. The data obtained from the study were analyzed using nonlinear mixed‐effects modeling approach. Data from 514 children, comprising a total of 2,998 plasma concentrations of LPV/r were included in the analysis. The LPV and RTV concentrations were accurately represented by a one‐compartment model with first‐order absorption (incorporating a lag‐time) and elimination. Body weight influenced LPV and RTV PK parameters. The impact of RTV concentrations on the CL/F of LPV was characterized using a maximum effect model. Simulation‐predicted target LPV exposures were achieved in children with this pellet formulation across the WHO weight bands. The LPV/r pellets dosed in accordance with WHO weight bands provide adequate LPV exposures in Kenyan and Ugandan children weighing 3.0 to 24.9 kg.
- 21 January 2024
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 115 (5) , 1105-1113
Open AccessPopulation Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in Africa
Antiretroviral therapy for children living with HIV (CLHIV) under 3 years of age commonly includes lopinavir/ritonavir (LPV/r). However, the original liquid LPV/r formulation has taste and cold storage difficulties. To address these challenges, LPV/r oral pellets have been developed. These pellets can be mixed with milk or food for administration and do not require refrigeration. We developed the population pharmacokinetic (PK) model and assessed drug exposure of LPV/r oral pellets administered twice daily to CLHIV per World Health Organization (WHO) weight bands. The PK analysis included Kenyan and Ugandan children participating in the LIVING studies (NCT02346487) receiving LPV/r pellets (40/10 mg) and ABC/3TC (60/30 mg) dispersible tablets. Population PK models were developed for lopinavir (LPV) and ritonavir (RTV) to evaluate the impact of RTV on the oral clearance (CL/F) of LPV. The data obtained from the study were analyzed using nonlinear mixed‐effects modeling approach. Data from 514 children, comprising a total of 2,998 plasma concentrations of LPV/r were included in the analysis. The LPV and RTV concentrations were accurately represented by a one‐compartment model with first‐order absorption (incorporating a lag‐time) and elimination. Body weight influenced LPV and RTV PK parameters. The impact of RTV concentrations on the CL/F of LPV was characterized using a maximum effect model. Simulation‐predicted target LPV exposures were achieved in children with this pellet formulation across the WHO weight bands. The LPV/r pellets dosed in accordance with WHO weight bands provide adequate LPV exposures in Kenyan and Ugandan children weighing 3.0 to 24.9 kg.
- Open Access
Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus
A cure for HIV-1 (HIV) remains unrealized due to a reservoir of latently infected cells that persist during antiretroviral therapy (ART), with reservoir size associated with adverse health outcomes and inversely with time to viral rebound upon ART cessation. Once established during ART, the HIV reservoir decays minimally over time; thus, understanding factors that impact the size of the HIV reservoir near its establishment is key to improving the health of people living with HIV and for the development of novel cure strategies. Yet, to date, few correlates of HIV reservoir size have been identified, particularly in pediatric populations. Here, we employed a cross-subtype intact proviral DNA assay (CS-IPDA) to quantify HIV provirus between one- and two-years post-ART initiation in a cohort of Kenyan children (n = 72), which had a median of 99 intact (range: 0–2469), 1340 defective (range: 172–3.84 × 104), and 1729 total (range: 178–5.11 × 104) HIV proviral copies per one million T cells. Additionally, pre-ART plasma was tested for HIV Env-specific antibody-dependent cellular cytotoxicity (ADCC) activity. We found that pre-ART gp120-specific ADCC activity inversely correlated with defective provirus levels (n = 68, r = −0.285, p = 0.0214) but not the intact reservoir (n = 68, r = −0.0321, p-value = 0.800). Pre-ART gp41-specific ADCC did not significantly correlate with either proviral population (n = 68; intact: r = −0.0512, p-value = 0.686; defective: r = −0.109, p-value = 0.389). This suggests specific host immune factors prior to ART initiation can impact proviruses that persist during ART.
Open AccessHigher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus
A cure for HIV-1 (HIV) remains unrealized due to a reservoir of latently infected cells that persist during antiretroviral therapy (ART), with reservoir size associated with adverse health outcomes and inversely with time to viral rebound upon ART cessation. Once established during ART, the HIV reservoir decays minimally over time; thus, understanding factors that impact the size of the HIV reservoir near its establishment is key to improving the health of people living with HIV and for the development of novel cure strategies. Yet, to date, few correlates of HIV reservoir size have been identified, particularly in pediatric populations. Here, we employed a cross-subtype intact proviral DNA assay (CS-IPDA) to quantify HIV provirus between one- and two-years post-ART initiation in a cohort of Kenyan children (n = 72), which had a median of 99 intact (range: 0–2469), 1340 defective (range: 172–3.84 × 104), and 1729 total (range: 178–5.11 × 104) HIV proviral copies per one million T cells. Additionally, pre-ART plasma was tested for HIV Env-specific antibody-dependent cellular cytotoxicity (ADCC) activity. We found that pre-ART gp120-specific ADCC activity inversely correlated with defective provirus levels (n = 68, r = −0.285, p = 0.0214) but not the intact reservoir (n = 68, r = −0.0321, p-value = 0.800). Pre-ART gp41-specific ADCC did not significantly correlate with either proviral population (n = 68; intact: r = −0.0512, p-value = 0.686; defective: r = −0.109, p-value = 0.389). This suggests specific host immune factors prior to ART initiation can impact proviruses that persist during ART.
- Open Access
- 5 October 2023
- Published by Oxford University Press (OUP) in Journal of the Pediatric Infectious Diseases Society
- Vol. 12 (11) , 574-580
Abacavir Drug Exposures in African Children Under 14 kg Using Pediatric Solid Fixed Dose Combinations According to World Health Organization Weight Bands
The pharmacokinetics of abacavir (ABC) in African children living with HIV (CLHIV) weighing 0–24) of 6.4–50.4 mg h/L were used as targets. Plasma samples were obtained from 387 children. A 1-compartment model with allometric scaling of clearance (CL/F) and volume of distribution (V/F) according to body weight best characterized the pharmacokinetic data of ABC. The maturation of ABC CL/F was characterized using a sigmoidal Emax model dependent on postnatal age (50% of adult CL/F reached by 0.48 years of age). Exposures to ABC were within the target range for children weighing 6.0–24.9 kg, but children weighing 3–5.9 kg were predicted to be overexposed. Lowering the ABC dosage to 30 mg twice daily or 60 mg once daily for children weighing 3–5.9 kg increased the proportion of children within the target and provided comparable exposures. Further clinical study is required to investigate clinical implications and safety of the proposed alternative ABC doses.
- 5 October 2023
- Published by Oxford University Press (OUP) in Journal of the Pediatric Infectious Diseases Society
- Vol. 12 (11) , 574-580
Open AccessAbacavir Drug Exposures in African Children Under 14 kg Using Pediatric Solid Fixed Dose Combinations According to World Health Organization Weight Bands
The pharmacokinetics of abacavir (ABC) in African children living with HIV (CLHIV) weighing 0–24) of 6.4–50.4 mg h/L were used as targets. Plasma samples were obtained from 387 children. A 1-compartment model with allometric scaling of clearance (CL/F) and volume of distribution (V/F) according to body weight best characterized the pharmacokinetic data of ABC. The maturation of ABC CL/F was characterized using a sigmoidal Emax model dependent on postnatal age (50% of adult CL/F reached by 0.48 years of age). Exposures to ABC were within the target range for children weighing 6.0–24.9 kg, but children weighing 3–5.9 kg were predicted to be overexposed. Lowering the ABC dosage to 30 mg twice daily or 60 mg once daily for children weighing 3–5.9 kg increased the proportion of children within the target and provided comparable exposures. Further clinical study is required to investigate clinical implications and safety of the proposed alternative ABC doses.
- Open Access
- 9 August 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (8) , e0289756
Prevalence, clinical presentation and factors associated with chronic lung disease among children and adolescents living with HIV in Kenya
Introduction: Children and adolescents with HIV (CAHIV) may experience recurrent and severe respiratory disease and are at risk of residual lung sequelae, and long-term morbidity from chronically damaged lungs. With improved survival due to increased access to effective antiretroviral therapy there is an increasing population of CAHIV who require optimal life-long care. Chronic lung disease in CAHIV is an under-recognised problem in African settings. We sought to determine the prevalence, clinical presentation and factors associated with chronic lung disease (CLD) among CAHIV in Kenya. Methods: CAHIV aged ≤19 years in care at a public hospital in Nairobi were enrolled into a longitudinal cohort study. Sociodemographic and clinical information were obtained through interview, medical record review, physical examination and six-minute walk test. CD4 counts and viral load were determined. Enrolment data was analysed to determine baseline sociodemographic and clinical characteristics. Prevalence of CLD defined as presence of ≥2 respiratory symptoms or signs at enrolment was computed. Logistic regression analysis was performed to evaluate for association between various factors and presence or absence of CLD. Results: We enrolled 320 CAHIV of median age 13 (IQR 10–16) years, 80 (25%) were <10 years, 46% were female, 31% lived in a one-room house and 51% used polluting cooking fuel. Antiretroviral therapy (ART) was initiated after age five years in 56%, 43% had prior pneumonia or tuberculosis, 11% had low CD4 count and 79% were virologically suppressed. Common respiratory symptoms and signs were exertional breathlessness (40%), chronic cough (23%), chest problems in the preceding year (24%), tachypnoea (52%), finger clubbing (6%), exercise limitation (59%) and oxygen desaturation during exercise (7%). CLD was present in 82 (26%) participants, and adding the six-minute walk distance <70% of predicted (exercise limitation) identified an additional 28 (9%) CAHIV with CLD. CLD was more common among older teenagers (odds ratio (OR) 1.95), those who had prior TB or pneumonia (OR 2.04), delayed initiation of ART (OR 2.60), cotrimoxazole prophylaxis (OR 3.35) or TB preventive therapy (OR 2.81). CLD was associated with viraemia (OR 2.7), lower quality of life (OR 12.7), small houses (OR 2.05), caregiver having fewer years of education (OR 2.46), outdoor pollution exposure (OR 3.31) and lower use of polluting cooking fuel indoors (OR 0.26). Adjusted analysis revealed CLD to be associated with prior tuberculosis or pneumonia (adjusted OR (aOR) [95%CI] 2.15 [1.18–3.91]), small house (aOR 1.95 [1.02–3.73]), lower use of polluting cooking fuel (aOR 0.35 [0.13–0.94]) and negative impact on health-related quality of life (aOR 6.91 [3.66–13.03]). Conclusions: CLD is highly prevalent across the age spectrum of CAHIV, and most are symptomatic with cough or exertional breathlessness. CLD is associated with prior tuberculosis or pneumonia, socio-environmental factors, and lower quality of life. Structured interventions are needed to provide optimal care specific to their needs.
- 9 August 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (8) , e0289756
Open AccessPrevalence, clinical presentation and factors associated with chronic lung disease among children and adolescents living with HIV in Kenya
Introduction: Children and adolescents with HIV (CAHIV) may experience recurrent and severe respiratory disease and are at risk of residual lung sequelae, and long-term morbidity from chronically damaged lungs. With improved survival due to increased access to effective antiretroviral therapy there is an increasing population of CAHIV who require optimal life-long care. Chronic lung disease in CAHIV is an under-recognised problem in African settings. We sought to determine the prevalence, clinical presentation and factors associated with chronic lung disease (CLD) among CAHIV in Kenya. Methods: CAHIV aged ≤19 years in care at a public hospital in Nairobi were enrolled into a longitudinal cohort study. Sociodemographic and clinical information were obtained through interview, medical record review, physical examination and six-minute walk test. CD4 counts and viral load were determined. Enrolment data was analysed to determine baseline sociodemographic and clinical characteristics. Prevalence of CLD defined as presence of ≥2 respiratory symptoms or signs at enrolment was computed. Logistic regression analysis was performed to evaluate for association between various factors and presence or absence of CLD. Results: We enrolled 320 CAHIV of median age 13 (IQR 10–16) years, 80 (25%) were <10 years, 46% were female, 31% lived in a one-room house and 51% used polluting cooking fuel. Antiretroviral therapy (ART) was initiated after age five years in 56%, 43% had prior pneumonia or tuberculosis, 11% had low CD4 count and 79% were virologically suppressed. Common respiratory symptoms and signs were exertional breathlessness (40%), chronic cough (23%), chest problems in the preceding year (24%), tachypnoea (52%), finger clubbing (6%), exercise limitation (59%) and oxygen desaturation during exercise (7%). CLD was present in 82 (26%) participants, and adding the six-minute walk distance <70% of predicted (exercise limitation) identified an additional 28 (9%) CAHIV with CLD. CLD was more common among older teenagers (odds ratio (OR) 1.95), those who had prior TB or pneumonia (OR 2.04), delayed initiation of ART (OR 2.60), cotrimoxazole prophylaxis (OR 3.35) or TB preventive therapy (OR 2.81). CLD was associated with viraemia (OR 2.7), lower quality of life (OR 12.7), small houses (OR 2.05), caregiver having fewer years of education (OR 2.46), outdoor pollution exposure (OR 3.31) and lower use of polluting cooking fuel indoors (OR 0.26). Adjusted analysis revealed CLD to be associated with prior tuberculosis or pneumonia (adjusted OR (aOR) [95%CI] 2.15 [1.18–3.91]), small house (aOR 1.95 [1.02–3.73]), lower use of polluting cooking fuel (aOR 0.35 [0.13–0.94]) and negative impact on health-related quality of life (aOR 6.91 [3.66–13.03]). Conclusions: CLD is highly prevalent across the age spectrum of CAHIV, and most are symptomatic with cough or exertional breathlessness. CLD is associated with prior tuberculosis or pneumonia, socio-environmental factors, and lower quality of life. Structured interventions are needed to provide optimal care specific to their needs.
- Top Cited PapersOpen Access
- 20 December 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (12) , e0000805
Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: A systematic review and meta-analysis
Background: Emerging evidence suggests that after completion of treatment for tuberculosis (TB) a significant proportion of patients experience sequelae. However, there is limited synthesized evidence on this from low-income countries, from Sub-Saharan Africa, and in HIV infected individuals. We seek to provide an updated comprehensive systematic review and meta-analysis on the magnitude and factors associated with post-TB lung disease (PTLD) in low- and middle-income countries (LMICs). Methods: We searched PubMed, Embase and CINAHL for studies from LMICs with data on post-TB lung health in patients who had previously completed treatment for pulmonary TB. Data on study characteristics, prevalence of PTLD–specifically abnormal lung function (spirometry), persisting respiratory symptoms and radiologic abnormalities were abstracted. Statistical analysis was performed using Microsoft Excel and R version 4.1 software, and random effects meta-analysis conducted to compute pooled prevalence of PTLD, evaluate heterogeneity, and assess factors associated with PTLD. Results: We identified 32 eligible studies with 6225 participants. Twenty-one studies were from Africa, 16 included HIV infected participants, spirometry was conducted in 20 studies, symptom assessment in 16 and chest imaging in eight. Pooled prevalence of abnormal lung function was 46.7%, persistent respiratory symptoms 41.0%, and radiologic abnormalities 64.6%. Magnitude of any type of PTLD varied by HIV status (HIV- 66.9%, HIV+ 32.8%, p = 0.0013), across geographic setting (SE Asia 57.5%, Southern America 50.8%, and Africa 38.2%, p = 0.0118), and across urban-rural settings (symptom prevalence: rural 68.8%, urban 39.1%, mixed settings 27.9%, p = 0.0035), but not by income settings, sex or age-group. Conclusions: There is high burden of post-TB persistent respiratory symptoms, functional lung impairment and radiologic structural abnormalities in individuals living in LMICs. Burden varies across settings and by HIV status. This evidence may be valuable to advocate for and inform implementation of structured health care specific to the needs of this vulnerable population of individuals.
- 20 December 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (12) , e0000805
Top Cited PapersOpen AccessMagnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: A systematic review and meta-analysis
Background: Emerging evidence suggests that after completion of treatment for tuberculosis (TB) a significant proportion of patients experience sequelae. However, there is limited synthesized evidence on this from low-income countries, from Sub-Saharan Africa, and in HIV infected individuals. We seek to provide an updated comprehensive systematic review and meta-analysis on the magnitude and factors associated with post-TB lung disease (PTLD) in low- and middle-income countries (LMICs). Methods: We searched PubMed, Embase and CINAHL for studies from LMICs with data on post-TB lung health in patients who had previously completed treatment for pulmonary TB. Data on study characteristics, prevalence of PTLD–specifically abnormal lung function (spirometry), persisting respiratory symptoms and radiologic abnormalities were abstracted. Statistical analysis was performed using Microsoft Excel and R version 4.1 software, and random effects meta-analysis conducted to compute pooled prevalence of PTLD, evaluate heterogeneity, and assess factors associated with PTLD. Results: We identified 32 eligible studies with 6225 participants. Twenty-one studies were from Africa, 16 included HIV infected participants, spirometry was conducted in 20 studies, symptom assessment in 16 and chest imaging in eight. Pooled prevalence of abnormal lung function was 46.7%, persistent respiratory symptoms 41.0%, and radiologic abnormalities 64.6%. Magnitude of any type of PTLD varied by HIV status (HIV- 66.9%, HIV+ 32.8%, p = 0.0013), across geographic setting (SE Asia 57.5%, Southern America 50.8%, and Africa 38.2%, p = 0.0118), and across urban-rural settings (symptom prevalence: rural 68.8%, urban 39.1%, mixed settings 27.9%, p = 0.0035), but not by income settings, sex or age-group. Conclusions: There is high burden of post-TB persistent respiratory symptoms, functional lung impairment and radiologic structural abnormalities in individuals living in LMICs. Burden varies across settings and by HIV status. This evidence may be valuable to advocate for and inform implementation of structured health care specific to the needs of this vulnerable population of individuals.